Billion-dollar private venture capital rounds are apparently now a "thing." Roivant sealed the deal on Wednesday, following a multi-year trend towards bigger investment rounds in the life sciences.
The orphan drug industry is somewhat static in growth, but significantly outpaces the mass market drug industry, according to a new report from EvaluatePharma.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.